Target intelligence / Profile preview

CD300 molecule like family member B (CD300LB)

Target
CD300LB
Molecular classification
Immunoglobulin superfamily, Receptor, Type I transmembrane protein
01

Overview

CD300 molecule like family member B (CD300LB or CD300b) is a protein-coding gene belonging to the immunoglobulin superfamily, functioning as a nonclassical activating receptor predominantly expressed on myeloid cells such as monocytes and granulocytes. CD300LB is a type I transmembrane protein characterized by a single extracellular IgV-like domain and a charged transmembrane residue necessary for interaction with adaptor molecules (notably DAP12), leading to immune cell activation. Signaling through CD300LB contributes to innate immune system pathways by modulating responses to pathogens and regulating inflammatory processes; its function is distinct from inhibitory CD300 family members, as it delivers activating signals via ITAM-containing adaptors and the GRB2 signaling pathway. The receptor's expression and activation can shape host immune responses in various disease states—such as infectious diseases, allergies, and cancer—making it a subject of therapeutic interest and a potential diagnostic target in immune-mediated pathologies.

Other names
CD300bCLM-7CLM7CMRF35-A2IREM-3IREM3TREM-5TREM5CMRF35-like molecule 7Triggering receptor expressed on myeloid cells 5Immune receptor expressed on myeloid cells 3CD300 antigen like family member BLeukocyte mono-Ig-like receptor 5
02

Mechanism of action

Activates immune effector functions via association with ITAM-bearing adaptors such as DAP12 (TYROBP) and through recruitment of GRB2

03

Biological functions

Activation of immune responseModulation of leukocyte (myeloid cell) functionSignal transduction in innate immunity
04

Disease associations

InfectionInflammationCancerOther pathological immune and inflammatory conditions
05

Safety considerations

Potential for dysregulation of immune/inflammatory signalingPossible off-target immune activation if therapeutically targeted

Beyond the preview

Go deeper on CD300 molecule like family member B (CD300LB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD300 molecule like family member B (CD300LB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call